We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Gunsynd invests; AQRU launches crypto-backed loans

Tue, 25th Oct 2022 14:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Sunrise Resources PLC - Macclesfield, England-based mineral project developer - Says Tolsa USA Inc receives approval for proposed trenching programme at Sunrise's Pioche Sepiolite project in Nevada from the US Bureau of Land Management. The reclamation bond has been submitted, and now up to two kilometres of excavator trenching is due to start this week. This will "better expose and sample" sepiolite deposits. Tolsa is the US subsidiary of Tolsa SA. Tolsa was granted a six-month option to purchase the Pioche project for USD1.3 million back in June and would pay a 3% royalty to Sunrise. The option is extendable for another 12 months upon payment of USD50,000 to Sunrise. Sunrise notes its focus remains on the CS and Hazen pozzolan projects, but Pioche is an example of its strategy to "identify overlooked mineral opportunities" to convert into cash and free carried royalty interests, "such as those the company already holds on the Junction, Garfield and Stonewall exploration projects".

----------

Georgia Capital PLC - Tbilisi, Georgia-based investor in businesses in Georgia - Announces results of its tender offer for outstanding USD365.0 million 6.125% notes due 2024 for cash. Aggregate principal amount of notes accepted for purchase is USD29.2 million, which it intends to cancel. Georgia Capital also will cancel another USD35.8 million in notes that it already owns, leaving USD300.0 million notes outstanding.

----------

Kavango Resources PLC - London-based mineral explorer focused on Botswana - Agrees to raise GBP500,000 from the issue of 27.8 million shares at 1.8 pence each. The shares will be conditionally issued via a direct subscription by a single strategic investor, Arigo Capital Ltd. Follows Monday's GBP3 million equity fundraise to put towards its plans in Botswana. "We are now extremely well positioned to pursue our ambition of making multiple major metal discoveries in Botswana," says CEO Ben Turney.

----------

Gunsynd PLC - London-based investment company focused on the natural resources, life sciences & alcohol sector - Invests AUD90,000, around GBP50,000, into Omega Oil & Gas Ltd. Omega is an Sydney-listed natural gas explorer and oil producer that began trading on the Australian Stock Exchange on Tuesday. It raised AUD15.1 million via the issue of 75.3 million shares at AUD0.20 each. Gunsynd subscribed for 450,000 shares at that price, now holding a 0.4% stake. Omega holds two exploration permits and a petroleum licence in the Surat-Bowen Basin in South-East Queensland, Australia. For the financial year that ended June 30, Omega recorded insubstantial revenue and a loss of AUD2.0 million.

----------

Deltic Energy PLC - AIM-listed natural resources investing company - Says the operator of the licence P2252, Shell UK Ltd, indicates that it is preparing to move the Maersk Resilient drilling rig to the Pensacola location, with mobilisation planned to occur in early November. Drilling is expected to start in mid-November, at which point Deltic will update further.

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Elects to draw GBP203,500 from its GBP10 million equity drawdown agreement with Crescita Capital LLC, into which it had entered last February. Accordingly, 18.5 million Clouadbreak shares are issued at 1.1p each. "The capital drawn down will be used to advance the company's acquisitions of energy royalties, lithium assets and bauxite projects globally," the company explains.

----------

Lamprell PLC - United Arab Emirates-based provider of oil field services - Confirms its London Main Market listing was cancelled as of Tuesday's market open. Shareholders had approved the delisting back in September.

----------

Gaming Realms PLC - London-based developer and licensor of mobile-focused gaming content - Officially launches its content in the US state of Connecticut, alongside its partner DraftKings Inc. Five games are now live, with a further nine to follow shortly. "Users will be able to play some of the company's top titles including Lucky Larry's Lobstermania Slingo, Blackjack X-Change, and our collaboration with the American Cancer Society - Slingo Gems," it says. Notes the US is a "significant" growth market for the firm, and it has a "number" of new operator launches planned.

----------

Ingenta PLC - Oxford, England-based provider of software and services to the publishing industry - Proposes tender offer to purchase 1.8 million shares at 115p each, which is around 11% of its issued share capital. Will have a general meeting on November 11.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Updates on its third quarter operations. At Tulu Kapi gold project in Ethiopia, says project costs were updated by suppliers, and it accommodated a 7% increase to capital requirements to USD320 million within the planned syndicate. Estimates that cash from the project in the first two years will be sufficient to repay debt. Earnings before interest, tax, depreciation and amortisation will average USD127 million annually in the first seven years, with USD89 million for Kefi's interest. Also plans to re-commence exploration of additional projects within Tulu Kapi district exploration area. Meanwhile, in Saudi Arabia, says its activities have benefited from the Saudi government's push to bring in international expertise and fast-track growth in the mining sector. Notes rapid progress in the quarter. "Going forward the company's Saudi assets are expected to have shorter gestation, approval, financing and development schedules," Kefi says.

----------

AQRU PLC - London-based incubator for decentralised finance businesses - Launches 'BlockLender', 'a start-up that offers cryptocurrency-collateralised lending services. BlockLender will enable digital assets-holders to access instant loans, using their cryptocurrency as collateral, starting from a minimum value of USD100. "While crypto-backed loans enable customers to use their digital assets to make real-life purchases, many providers have taken on excessive levels of risk with people's assets, without their customers knowing. With the launch of BlockLender, AQRU is bringing much-needed transparency to the evolving digital asset lending market," says CEO Philip Blows, who also will be managing director at BlockLender.

----------

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms its name change to hVIVO PLC will take effect from Wednesday. The firm previously explained it will take on the moniker of its clinical research subsidiary, and said the name change will better reflect its core human challenge and early clinical services business.

----------

MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Announces results of open label clinical study, for a white label version of ArtemiC Support. The study was conducted on 60 Covid-vaccinated participants in Spain who were suffering from post-acute Covid, also known as long Covid. The nutraceutical was administered in 10 drops twice a day for six weeks, and proved to alleviate symptoms of the long Covid, which relate to functional limitations. These include pain, mental confusion, sleep disorders, and inflammation. "The biological markers in the blood tests further proved a reduction of inflammation and enterohepatic involvement, as well as liver reactant proteins," it explains. "The clinical study has demonstrated that MGC Pharma's ArtemiC Rescue formulation has markedly affected outward symptoms of Long-COVID, which is an excellent step forward in progressing the clinical proof of the benefits of ArtemiC," says Co-Founder & Managing Director Roby Zomer.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Mar 2024 15:42

UK shareholder meetings calendar - next 7 days

Tuesday 12 March 
Impax Asset Management Group PLCAGM
Seed Capital Solutions PLCAGM
Shoe Zone PLCAGM
Wednesday 13 March 
abrdn China Investment Co LtdGM re liquidation
Safestore Holdings PLCAGM
Wincanton PLCGM re takeover by CEVA Logistics
Thursday 14 March 
Angus Energy PLCGM
Bank of Georgia Group PLCGM re acquisition of Ameriabank CJSC
Blackrock Sustainable American Income Trust PLCAGM
Friday 15 March 
BlackRock Energy & Resources Income Trust PLCAGM
Chrysalis Investments LtdAGM
Quantum Exponential Group PLCGM re delisting from AQSE
TruSpine Technologies PLCAGM (adjourned 2022)
United Oil & Gas PLCGM re fundraise and share sub-division
Monday 18 March 
MGC Pharmaceuticals LtdGM re change of company name to Argent Biopharma
Schroder European Real Estate Investment Trust PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Feb 2024 17:00

EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Feb 2024 11:54

IN BRIEF: MGC Pharmaceuticals proposes name change to Argent Biopharma

MGC Pharmaceuticals Ltd - pharmaceutical company specialising in plant-derived medicines - Calls general meeting for March 18 on resolution to change the company's name to Argent Biopharma Ltd. "The board proposes this change of name on the basis that it believes the proposed name more accurately reflects the future operations of the company," the firm says.

Read more
19 Dec 2023 18:04

MGC Pharma gets Saudi approval for Covid-19 over-the-counter treatment

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said the Saudi Arabian Food & Drug Authority has granted approval for its proprietary Covid-19 treatment product ArtemiC as an over-the-counter dietary supplement.

Read more
23 Nov 2023 15:53

UK shareholder meetings calendar - next 7 days

Friday 24 November 
Base Resources LtdAGM
Cloudbreak Discovery PLCAGM
Esken LtdEGM re Esken Renewables disposal
Neometals LtdAGM
Sovereign Metals LtdAGM
Sylvania Platinum LtdAGM
Monday 27 November 
Chelverton Growth Trust PLCGM re voluntary liquidation
European Smaller Cos Trust PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Quadrise PLCAGM
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Tuesday 28 November 
Bluefield Solar Income Fund LtdAGM
London Finance & Investment Group PLCAGM
Nanoco Group PLCAGM
Oakley Capital Investments LtdAGM
Wednesday 29 November 
Artemis Resources LtdAGM
Aura Energy LtdAGM
Contango Holdings PLCAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Ikigai Ventures LtdAGM
Panthera Resources PLCAGM
Reconstruction Capital II LtdAGM
Renishaw PLCAGM
RiverFort Global Opportunities PLCAGM
Sabien Technology Group PLCAGM
Scancell Holdings PLCAGM
Seeing Machines LtdAGM
SLF Realisation Fund LtdAGM
Target Healthcare REIT PLCAGM
Thor Energy PLCAGM
Transense Technologies PLCAGM
Vast Resources PLCAGM
Thursday 30 November 
Amur Minerals CorpAGM
Atlantic Lithium LtdAGM
Cordel Group PLCAGM
CQS New City High Yield Fund LtdAGM
DXS International PLCAGM
Europa Metals LtdAGM
Gabelli Merger Plus+ Trust PLCAGM
Kingswood Holdings LtdAGM
MC Mining LtdAGM
MGC Pharmaceuticals LtdAGM
NCC Group PLCAGM
Ovoca Bio PLCAGM
Revolution Bars Group PLCAGM
Roebuck Food Group PLCEGM re fundraising
Ruffer Investment Co LtdAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 16:54

TRADING UPDATES: Premier Miton sizes up Tellworth Investments

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
18 Oct 2023 15:45

UK shareholder meetings calendar - next 7 days

Thursday 19 October 
Argo Group LtdAGM
Bridgepoint Group PLCGM re adding Energy Capital to platform
Direct Line Insurance Group PLCGM re sale of brokered commercial insurance business lines to RSA Insurance Ltd
Medtronic PLCAGM
Pantheon International PLCAGM
Rank Group PLCAGM
Friday 20 October 
GSTechnologies LtdAGM
Monday 23 October 
abrdn New Dawn Investment Trust PLCGM re scheme and associated amendments to Company's articles
City of London Investment Group PLCAGM
Finsbury Food Group PLCGM re takeover by Frisbee Bidco
Landore Resources LtdEGM re fundraising
Mothercare PLCAGM
Naked Wines PLCGM re annual report and accounts
Oracle Power PLCGM re capital reorganisation
Provexis PLCAGM
Tuesday 24 October 
Accrol Group Holdings PLCAGM
Oneiro Energy PLCAGM
Tufton Oceanic Assets LtdAGM
WH Ireland Group PLCAGM
Wednesday 25 October 
Arcontech Group PLCAGM
Hargreaves Services PLCAGM
Kavango Resources PLCGM re takeover
MGC Pharmaceuticals LtdGM re consolidation of capital, share placement
Pendragon PLCGM re strategic partnership with Lithia and name change to Pinewood Technologies PLC
Springfield Properties PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
29 Sep 2023 12:26

EARNINGS: MGC Pharmaceuticals loss widens, Codex eyes acquisitions

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
26 Sep 2023 10:31

UPDATE: MGC Pharmaceuticals proposes share placement at 80% discount

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday warned it is at a "critical financial juncture" with its share price having failed to appreciate and fundraising efforts during the year having been underwhelming.

Read more
26 Sep 2023 10:19

MGC Pharmaceuticals at "critical financial juncture" despite progress

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday warned it is at a "critical financial juncture" with its share price having failed to appreciate and fundraising efforts during the year having been underwhelming.

Read more
26 Sep 2023 09:52

SMALL-CAP WINNERS & LOSERS: MGC Pharma drops on restructuring plan

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Read more
31 Aug 2023 20:30

MGC Pharmaceuticals annual loss widens as revenue falls

(Alliance News) - MGC Pharmaceuticals Ltd reported an increased loss and and a lower revenue in the financial year that ended on June 30.

Read more
29 Aug 2023 15:45

UK shareholder meetings calendar - next 7 days

Wednesday 30 August 
Esken LtdAGM
Gfinity PLCGM re share capital reorganisation
Global Connectivity PLCAGM
Gresham House PLCGM re takeover
Kinovo PLCAGM
Lindsell Train Investment Trust PLCAGM
Vistry Group PLCGM re directors' remuneration policy
WANdisco PLCAGM
Thursday 31 August 
Ajax Resources PLCAGM
Cairn Homes PLCEGM re adoption of Stretch CEO LITP
Carclo PLCAGM
Global Ports Holding PLCAGM
Gowin New Energy Group LtdAGM
HealthBeacon PLCAGM
Spectral MD Holdings LtdGM re Rosecliff Acquisition Corp combination
Triple Point Energy Transition PLCAGM
Watches of Switzerland Group PLCAGM
Friday 1 September 
Totally PLCAGM
Triple Point Income VCT PLCGM re voluntary liquidation
Monday 4 September 
Concurrent Technologies PLCGM re acquisition of Phillips Machine & Welding Co Inc
Tuesday 5 September 
Brickability Group PLCAGM
DS Smith PLCAGM
Iomart Group PLCAGM
Lookers PLCGM and court meeting re takeover by Global Auto
MGC Pharmaceuticals LtdGM re approval to issue SPP and shortfall options
Renold PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
14 Aug 2023 10:35

MGC Pharmaceuticals hails positive toxicology results for CimetrA

(Alliance News) - MGC Pharmaceuticals Ltd on Monday announced positive pre-clinical trial results from a pre-clinical chronic toxicology evaluation of a 14-day oral dose of CimetrA.

Read more
31 Jul 2023 17:31

TRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.